Stein: Getec takes over Life Science Park Rheintal from Novartis

The pharmaceutical group Novartis is placing the further development of its Life Science Park Rheintal in Stein (AG) in the hands of the industrial park operator Getec. The aim is to maximize the economic potential of the park and develop it professionally, according to Novartis.

The real estate, infrastructure-related assets and services are to be transferred by the end of the year. Novartis will remain the largest tenant at the site. The Group operates a production plant in Stein for solid dosage forms, drugs for injection, cell and gene therapies as well as a grinding and mixing center for chemical production.

A third of the area is unused

Getec has been operating the infrastructure in Schweizerhalle for Novartis and other companies since 2019. According to a press release from Novartis, the company intends to develop the Life Science Park Rheintal in a long-term and sustainable manner and invest in the site in order to attract new tenants. Around a third of the site is currently unused.

Novartis founded the Life Science Park Rheintal at the beginning of 2021 to attract additional companies to the site. In addition to Novartis, the chemical and pharmaceutical company Lonza has been represented in Stein since 2019 and signed an agreement to expand its production capacities in June 2022. The biotechnology company Celonic has been based there since the beginning of 2021. A total of 2,000 people work in the Rhine Valley Life Science Park.

The park offers services in the areas of building management, energy supply, engineering, maintenance, logistics and environmentally friendly wastewater treatment and waste disposal for the companies located there. (ah)